|
|
 |
|
Viewing report
|
|
|
|
Bayer HealthCare AG - Product Pipeline Analysis
GlobalData, Aug 2011, Pages: 32
Bayer HealthCare AG - Product Pipeline Analysis
Summary
Bayer HealthCare AG (Bayer Healthcare), a division of the Bayer Group is engaged in the design, research, development, manufacture and sale of medical products for the health care industry. The company develops innovative products such as animal health care products, consumer care products, blood glucose monitoring systems, diagnostic imaging products, oncology products and primary care products. It operates through four business divisions, namely, Animal Health, Consumer Care, Medical Care and Bayer Schering Pharma AG. Bayer Healthcare’s products are marketed across the world through regional and national distribution companies. It operates in more than 100 countries and has over 50 manufacturing facilities across five continents. The company is headquartered in Leverkusen, Germany.
This report is a source for data, analysis and actionable intelligence on the Bayer HealthCare AG portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Customers who bought this item also bought
Sensile Medical AG - Product Pipeline Analysis
Elan Corporation, plc (ELN) - Product Pipeline Analysis
Abbott Laboratories (ABT) - Product Pipeline Analysis
Proteus Biomedical, Inc. - Product Pipeline Analysis
Bayer HealthCare AG - Strategic SWOT Analysis Review
Biosign Technologies Inc. (BIO) - Product Pipeline Analysis
Siemens Healthcare Diagnostics, Inc. - Product Pipeline Analysis
Ortho-Clinical Diagnostics Inc. - Product Pipeline Analysis
Philips Healthcare - Product Pipeline Analysis
CareFusion Corporation (CFN) - Product Pipeline Analysis
|
|
|
|
